Device Automated Insulin Delivery System

Ilet Insulin Infusion Kit Inset

Payments companies reported to CMS as associated with Ilet Insulin Infusion Kit Inset. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$287Kassociated payments (2023-2025)
3,877clinicians with associated payments
1company reporting

By year

2025 $287K

Payments reported as associated with Ilet Insulin Infusion Kit Inset, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Endocrinology, Diabetes & Metabolism $126K
Family $47K
Physician Assistant $25K
Nurse Practitioner $19K
Pediatric Endocrinology $16K
Internal Medicine $13K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Ilet Insulin Infusion Kit Inset

These are the largest totals companies reported as associated with Ilet Insulin Infusion Kit Inset. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Bantwal Baliga Opelika, AL Endocrinology, Diabetes & Metabolism $1,050.88
Kalpana Reddy Flushing, NY Endocrinology, Diabetes & Metabolism $886.58
Julie Rogers Shavano Park, TX Family $830.96
Kecia Ford East Meadow, NY Internal Medicine $770.49
Jennifer Hawkins Gilbert, AZ Nurse Practitioner $747.37
Rocio Harbison Houston, TX Endocrinology, Diabetes & Metabolism $735.46
Gregory Dodell New York City, NY Endocrinology, Diabetes & Metabolism $711.79
Seema Ahluwalia Chandler, AZ Endocrinology, Diabetes & Metabolism $709.17
Daniel Tung Houston, TX Endocrinology, Diabetes & Metabolism $685.47
Raya Galibov New York, NY Physician Assistant $655.11

Prescribed Ilet Insulin Infusion Kit Inset?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.